Indivior, Braeburn, And Two Very Well-Timed Anti-Addiction Applications

US FDA advisory committee had dosing and dispensing concerns about both buprenorphine injectable products, but each ended up with a strong vote in favor, clearly benefiting from public health attention to opioid addiction and the call for broader access to treatment.